7Baggers
Quarterly
Annual
    Unit: USD2025-07-31 2025-04-30 2025-01-31 2024-10-31 2024-07-31 2024-04-30 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31 2022-10-31 2022-07-31 2022-04-30 2022-01-31 2021-10-31 2021-07-31 2021-04-30 2021-01-31 2020-10-31 2020-07-31 2020-04-30 2020-01-31 2019-10-31 2019-07-31 2019-04-30 2019-01-31 2018-10-31 2018-07-31 2018-04-30 2018-01-31 2017-10-31 2017-07-31 2017-04-30 2017-01-31 2016-10-31 
      
    		                                    
      cash flows from operating activities:
    		                                    
      net earnings attributable to hpe
    		305,000,000 -1,050,000,000 627,000,000                                  
      adjustments to reconcile net earnings attributable to hpe to net cash from operating activities:
    		                                    
      depreciation and amortization
    		687,000,000 574,000,000 599,000,000 640,000,000 625,000,000 642,000,000 657,000,000 655,000,000 654,000,000 651,000,000 656,000,000 618,000,000 620,000,000 621,000,000 621,000,000 641,000,000 643,000,000 639,000,000 674,000,000 652,000,000 642,000,000 641,000,000 690,000,000 616,000,000 632,000,000 648,000,000 639,000,000 645,000,000 641,000,000 655,000,000 635,000,000 682,000,000 737,000,000 792,000,000 840,000,000 872,000,000 
      impairment of goodwill
    		0                   0 0                
      stock-based compensation expense
    		177,000,000 116,000,000 154,000,000 89,000,000 80,000,000 120,000,000 141,000,000 71,000,000 91,000,000 126,000,000 140,000,000 85,000,000 64,000,000 114,000,000 128,000,000 78,000,000 86,000,000 105,000,000 113,000,000 59,000,000 55,000,000 67,000,000 93,000,000 61,000,000 58,000,000 74,000,000 75,000,000 44,000,000 56,000,000 83,000,000 103,000,000 79,000,000 97,000,000 107,000,000 145,000,000 126,000,000 
      benefit from inventory and credit losses
    		149,000,000 123,000,000 67,000,000 50,000,000 12,000,000 81,000,000 32,000,000  92,000,000                            
      restructuring (credit) charges
    		0                                    
      cost reduction program
    		2,000,000                                    
      deferred taxes on earnings
    		-31,000,000 -41,000,000 -2,000,000 -80,000,000   -22,000,000 -65,000,000 -71,000,000 49,000,000 20,000,000 -188,000,000 -7,000,000 -91,000,000 37,000,000 -11,000,000 -61,000,000 -24,000,000 -71,000,000 -80,000,000 -111,000,000 -75,000,000 -28,000,000 194,000,000 541,000,000 -26,000,000 370,000,000 3,444,000,000 -51,000,000 171,000,000 -1,335,000,000 -1,267,000,000 -361,000,000 631,000,000 -125,000,000 -333,000,000 
      earnings from equity interests
    		-32,000,000 -25,000,000 -17,000,000 14,000,000 -73,000,000 -42,000,000 -46,000,000 -65,000,000 -73,000,000 -49,000,000 -58,000,000 -83,000,000 -68,000,000 -33,000,000 -31,000,000 -71,000,000 -79,000,000 -4,000,000 -26,000,000 -17,000,000 -27,000,000 10,000,000 -33,000,000  -3,000,000 -3,000,000 -15,000,000          
      gain on sale of a business
    		-1,000,000 0 -244,000,000                                  
      dividends received from equity investees
    		   0    166,000,000    159,000,000    146,000,000             0        
      h3c divestiture related severance costs
    		0 20,000,000 77,000,000                                  
      other
    		115,000,000 -19,000,000 60,000,000 -11,000,000 32,000,000 56,000,000 72,000,000 38,000,000 4,000,000 49,000,000 -60,000,000 316,000,000 40,000,000 -19,000,000 -27,000,000 85,000,000 55,000,000 -3,000,000 65,000,000 48,000,000 107,000,000 44,000,000 -36,000,000 70,000,000 89,000,000 -1,000,000 46,000,000 -213,000,000 -42,000,000 -5,000,000 102,000,000 151,000,000 82,000,000 185,000,000 125,000,000 81,000,000 
      changes in operating assets and liabilities, net of acquisitions:
    		                                    
      accounts receivable
    		-758,000,000 -463,000,000 91,000,000 300,000,000 -7,000,000 -66,000,000 -310,000,000 -46,000,000 253,000,000 482,000,000 -112,000,000 -743,000,000 -260,000,000 274,000,000 543,000,000 -652,000,000 -371,000,000 -14,000,000 446,000,000 -530,000,000 -254,000,000 241,000,000 82,000,000 59,000,000 172,000,000 30,000,000 113,000,000 -357,000,000 179,000,000 -8,000,000 -34,000,000 207,000,000 -51,000,000 -165,000,000 466,000,000 3,000,000 
      financing receivables
    		-28,000,000 -292,000,000 317,000,000 -598,000,000 16,000,000 -137,000,000 -190,000,000 263,000,000 -204,000,000 -143,000,000 -523,000,000 121,000,000 103,000,000 289,000,000 181,000,000 -191,000,000 130,000,000 16,000,000 -120,000,000 -76,000,000 -338,000,000 31,000,000 -104,000,000 -85,000,000 -293,000,000 124,000,000 -156,000,000 -138,000,000 44,000,000 15,000,000 -287,000,000 -335,000,000 -247,000,000 -6,000,000 126,000,000 -49,000,000 
      inventory
    		1,820,000,000 376,000,000 -811,000,000 -163,000,000 -387,000,000 -1,347,000,000 -1,461,000,000 -91,000,000 -291,000,000 287,000,000 495,000,000 387,000,000 -239,000,000 -27,000,000 -834,000,000 -607,000,000 -855,000,000 -349,000,000 -148,000,000 726,000,000 -57,000,000 -992,000,000 -204,000,000 -20,000,000 -87,000,000 54,000,000 99,000,000 285,000,000 42,000,000 -441,000,000 -146,000,000 -201,000,000 -131,000,000 -78,000,000 -132,000,000 31,000,000 
      accounts payable
    		-897,000,000 -1,434,000,000 -264,000,000 925,000,000 -24,000,000 1,985,000,000 1,041,000,000 1,491,000,000 74,000,000 -1,025,000,000 -2,195,000,000 1,878,000,000 1,152,000,000 -885,000,000 -438,000,000 458,000,000 986,000,000 325,000,000 -161,000,000 -656,000,000 504,000,000 177,000,000 -250,000,000 301,000,000 -261,000,000 -309,000,000 -256,000,000 -99,000,000 -105,000,000 284,000,000 -107,000,000 340,000,000 523,000,000 360,000,000 -231,000,000 749,000,000 
      taxes on earnings
    		-69,000,000 -85,000,000 49,000,000 82,000,000 13,000,000 28,000,000 67,000,000 -60,000,000 27,000,000 -47,000,000 46,000,000 111,000,000 4,000,000 146,000,000 -111,000,000 -67,000,000 24,000,000 4,000,000 -34,000,000 -37,000,000 40,000,000 -98,000,000 -27,000,000 28,000,000 -936,000,000 -78,000,000 -107,000,000 -2,245,000,000 -54,000,000 -1,208,000,000 -1,009,000,000 337,000,000 -216,000,000 -364,000,000 -22,000,000 834,000,000 
      restructuring
    		-14,000,000 -16,000,000 -16,000,000 -20,000,000 -23,000,000 -43,000,000 -78,000,000 -74,000,000 -54,000,000 -51,000,000 -96,000,000 -67,000,000 -70,000,000 -83,000,000 -114,000,000 -101,000,000 -102,000,000 -104,000,000 -220,000,000 -128,000,000 -106,000,000 -157,000,000 -87,000,000 -70,000,000 -63,000,000 -88,000,000 -110,000,000 -107,000,000 -126,000,000 -188,000,000 -226,000,000 -112,000,000 -143,000,000 -219,000,000 -326,000,000 -298,000,000 
      other assets and liabilities
    		-120,000,000 261,000,000 -1,077,000,000 156,000,000 317,000,000 -531,000,000 -233,000,000 -232,000,000 487,000,000 67,000,000 240,000,000 -296,000,000 -590,000,000 -375,000,000 -627,000,000 540,000,000 67,000,000 -208,000,000 -62,000,000 183,000,000 588,000,000 -84,000,000 -633,000,000 -422,000,000 1,146,000,000 48,000,000 -568,000,000 422,000,000 38,000,000 -80,000,000 817,000,000 -102,000,000 247,000,000 -222,000,000 -2,729,000,000 -309,000,000 
      net cash from operating activities
    		1,305,000,000 -461,000,000 -390,000,000 2,030,000,000 1,154,000,000 1,093,000,000 64,000,000 2,843,000,000 1,525,000,000 889,000,000 -829,000,000 3,036,000,000 1,254,000,000 379,000,000 -76,000,000 2,956,000,000 1,130,000,000 822,000,000 963,000,000 747,000,000 1,472,000,000 100,000,000 -79,000,000 1,432,000,000 1,196,000,000 987,000,000 382,000,000 1,326,000,000 1,249,000,000 247,000,000 142,000,000 826,000,000 891,000,000 636,000,000 -1,464,000,000 2,212,000,000 
      cash flows from investing activities:
    		                                    
      investment in property, plant and equipment and software assets
    		-576,000,000 -547,000,000 -528,000,000 -608,000,000                                 
      proceeds from sale of property, plant and equipment
    		90,000,000 80,000,000 84,000,000 90,000,000 62,000,000 122,000,000 96,000,000 255,000,000 102,000,000 86,000,000 159,000,000 238,000,000 106,000,000 135,000,000 123,000,000 80,000,000 80,000,000 81,000,000 113,000,000 80,000,000 72,000,000 89,000,000 462,000,000 149,000,000 77,000,000 214,000,000 157,000,000 533,000,000 269,000,000 177,000,000 115,000,000 276,000,000 261,000,000 58,000,000 84,000,000 133,000,000 
      purchases of equity investments
    		                                    
      proceeds from sale of available-for-sale securities
    		                                    
      proceeds from maturities and redemptions of available-for-sale securities
    		                                    
      financial collateral posted
    		-117,000,000   -292,000,000 -229,000,000 -60,000,000 -439,000,000 -33,000,000 -401,000,000 -327,000,000 -682,000,000 -108,000,000 0 -30,000,000 -10,000,000 -30,000,000 -242,000,000 -365,000,000 -266,000,000 -71,000,000 -522,000,000 -3,000,000 -48,000,000 -71,000,000 -17,000,000 -70,000,000 -245,000,000 -229,000,000 -127,000,000 -485,000,000 -706,000,000 -302,000,000 -158,000,000    
      financial collateral received
    		231,000,000 77,000,000 210,000,000 340,000,000 237,000,000 130,000,000 271,000,000 359,000,000 310,000,000 375,000,000 108,000,000 0 102,000,000 119,000,000 153,000,000 25,000,000 483,000,000 277,000,000 20,000,000 28,000,000 24,000,000 466,000,000 147,000,000              
      payments made in connection with business acquisitions, net of cash acquired
    		       0 -355,000,000 -374,000,000 -32,000,000     -372,000,000 -99,000,000   -853,000,000 0 -7,000,000 -6,000,000 -1,445,000,000 -5,000,000 0 -76,000,000 0 -178,000,000   -152,000,000 0 -1,758,000,000 -292,000,000 0 
      proceeds from sale of a business
    		0 0 210,000,000                                  
      net cash from investing activities
    		-12,602,000,000 -989,000,000 -23,000,000 1,527,000,000 -473,000,000 -367,000,000 -740,000,000 -98,000,000 -1,016,000,000 -933,000,000 -1,237,000,000 -863,000,000 -397,000,000 -492,000,000 -335,000,000 -1,079,000,000 -486,000,000 -579,000,000 -652,000,000 -1,424,000,000 -1,050,000,000 -40,000,000 -64,000,000 -2,058,000,000 -335,000,000 -448,000,000 -616,000,000 -388,000,000 -414,000,000 -150,000,000 -1,119,000,000 -483,000,000 -614,000,000 -2,653,000,000 -1,157,000,000 -211,000,000 
      cash flows from financing activities:
    		                                    
      short-term borrowings with original maturities less than 90 days
    		19,000,000 -20,000,000 9,000,000 19,000,000 -5,000,000 -28,000,000 -17,000,000 7,000,000 -398,000,000 -401,000,000 745,000,000 -14,000,000 58,000,000 3,000,000 53,000,000 -6,000,000 -69,000,000 13,000,000 26,000,000 -45,000,000 -46,000,000 -45,000,000 127,000,000 -78,000,000 0 37,000,000 -12,000,000 -79,000,000 109,000,000 -22,000,000 -3,000,000 -12,000,000 2,000,000 4,000,000 24,000,000 -20,000,000 
      proceeds from debt, net of issuance costs
    		5,076,000,000 152,000,000 105,000,000 9,089,000,000 1,081,000,000 216,000,000 859,000,000 839,000,000 1,041,000,000 2,584,000,000 261,000,000 788,000,000 926,000,000 306,000,000 1,276,000,000 324,000,000 1,066,000,000 1,309,000,000 323,000,000 262,000,000 3,180,000,000 3,225,000,000 340,000,000 2,507,000,000 385,000,000 236,000,000 389,000,000 1,563,000,000 283,000,000 341,000,000 270,000,000 -1,081,000,000 2,799,000,000    
      payment of debt
    		-602,000,000 -575,000,000 -486,000,000 -2,681,000,000 -576,000,000 -1,703,000,000 -515,000,000 -1,825,000,000 -634,000,000 -1,767,000,000 -661,000,000 -2,051,000,000 -601,000,000 -707,000,000 -633,000,000 -3,124,000,000 -597,000,000 -1,133,000,000 -611,000,000 -3,700,000,000 -468,000,000 -481,000,000 -450,000,000 -1,331,000,000 -312,000,000 -226,000,000 -334,000,000 -1,600,000,000 -1,928,000,000 -357,000,000 -253,000,000 -1,487,000,000 -194,000,000 -1,840,000,000 -262,000,000 -265,000,000 
      net payments related to stock-based award activities
    		-58,000,000 -2,000,000 -169,000,000 -15,000,000 25,000,000 0 -94,000,000 -6,000,000 6,000,000 1,000,000 -107,000,000                          
      repurchases of common stock
    		0 -50,000,000 -52,000,000                                  
      cash dividends paid to non-controlling interests, net of contributions
    		0 0 -8,000,000 0 0 0 -8,000,000                              
      cash dividends paid to preferred stockholders
    		-29,000,000 -29,000,000 -25,000,000                                  
      cash dividends paid to common stockholders
    		-171,000,000 -171,000,000 -171,000,000                                  
      net cash from financing activities
    		4,235,000,000 -695,000,000 -797,000,000 7,655,000,000 304,000,000 -1,729,000,000 53,000,000 -1,194,000,000 -331,000,000 154,000,000 9,000,000 -1,580,000,000 44,000,000 -615,000,000 355,000,000 -3,197,000,000 252,000,000 40,000,000 -459,000,000 -3,639,000,000 2,525,000,000 2,382,000,000 -385,000,000 691,000,000 -639,000,000 -655,000,000 -945,000,000 -1,251,000,000    1,479,000,000 -621,000,000 260,000,000 -508,000,000 -34,000,000 
      effect of exchange rate changes on cash, cash equivalents, and restricted cash
    		-29,000,000 81,000,000 -43,000,000 -12,000,000 -4,000,000 -45,000,000 14,000,000 -102,000,000 -1,000,000 1,000,000 138,000,000                          
      change in cash, cash equivalents and restricted cash
    		-7,091,000,000 -2,064,000,000 -1,253,000,000                                  
      cash, cash equivalents and restricted cash at beginning of period
    		0 0 15,105,000,000 0 0 0 4,581,000,000 0 0 0 4,763,000,000 0 0 0 4,332,000,000 0 0 0 4,621,000,000 0 0 0 4,076,000,000 0 0 0 5,084,000,000          
      cash, cash equivalents and restricted cash at end of period
    		-7,091,000,000 -2,064,000,000 13,852,000,000 11,200,000,000 981,000,000 -1,048,000,000 3,972,000,000 1,449,000,000 177,000,000 111,000,000 2,844,000,000 314,000,000 901,000,000 -728,000,000 4,276,000,000 -1,320,000,000 896,000,000 283,000,000 4,473,000,000 -4,316,000,000 2,947,000,000 2,442,000,000 3,548,000,000 65,000,000 222,000,000 -116,000,000 3,905,000,000          
      purchases of investments
    		   0 0 0 -16,000,000 -5,000,000 -5,000,000   -1,000,000 -14,000,000 -19,000,000 -21,000,000                      
      proceeds from maturities and sales of investments
    		 40,000,000 1,000,000 2,144,000,000 0 1,000,000 4,000,000 1,000,000 4,000,000 0 4,000,000 8,000,000 182,000,000 28,000,000 44,000,000                      
      restructuring charges
    		   13,000,000 2,000,000 11,000,000 7,000,000 109,000,000 38,000,000 23,000,000 72,000,000 112,000,000 34,000,000 31,000,000 37,000,000 128,000,000 126,000,000 134,000,000 232,000,000 216,000,000 305,000,000 164,000,000 84,000,000 75,000,000 94,000,000 19,000,000 33,000,000 151,000,000 131,000,000 94,000,000 174,000,000 406,000,000 165,000,000 216,000,000 177,000,000 395,000,000 
      gain on sale of equity interest
    		                                    
      cash settlement for derivative hedging debt
    		       0                             
      proceeds from issuance of 7.625% series c mandatory convertible preferred stock, net of issuance costs
    		                                    
      repurchase of common stock
    		   -50,000,000 -52,000,000 -45,000,000 -3,000,000 -55,000,000 -187,000,000 -106,000,000 -73,000,000 -128,000,000 -197,000,000 -58,000,000 -129,000,000     0 0 -151,000,000 -204,000,000 -284,000,000 -577,000,000 -574,000,000 -814,000,000 -983,000,000 -936,000,000 -907,000,000 -742,000,000 -620,000,000 -625,000,000 -670,000,000 -641,000,000 0 
      cash dividends paid to shareholders
    		   -169,000,000 -169,000,000 -169,000,000 -169,000,000 -154,000,000 -154,000,000 -155,000,000 -156,000,000 -154,000,000 -156,000,000 -156,000,000 -155,000,000 -157,000,000 -157,000,000                    
      supplemental cash flow disclosures:
    		                                    
      income taxes paid, net of refunds
    		                                    
      interest expense paid
    		                                    
      net earnings
    		    512,000,000 314,000,000 387,000,000 642,000,000 464,000,000 418,000,000 501,000,000 -304,000,000 409,000,000 250,000,000 513,000,000 2,553,000,000 392,000,000 259,000,000 223,000,000 157,000,000 9,000,000 -821,000,000 333,000,000 480,000,000 -27,000,000 419,000,000 177,000,000 -757,000,000 451,000,000 778,000,000 1,436,000,000 524,000,000 165,000,000 -612,000,000 267,000,000 302,000,000 
      adjustments to reconcile net earnings to net cash from operating activities:
    		                                    
      decrease in cash, cash equivalents and restricted cash
    		    981,000,000 -1,048,000,000 -609,000,000   111,000,000 -1,919,000,000    -56,000,000    -148,000,000    -528,000,000  222,000,000 -116,000,000 -1,179,000,000          
      investment in property, plant and equipment
    		     -560,000,000 -656,000,000 -675,000,000 -671,000,000 -688,000,000 -794,000,000 -1,000,000,000 -773,000,000 -725,000,000 -624,000,000 -770,000,000 -684,000,000 -535,000,000 -513,000,000 -604,000,000 -620,000,000 -591,000,000 -568,000,000 -703,000,000 -625,000,000 -799,000,000 -729,000,000 -827,000,000 -767,000,000 -693,000,000 -669,000,000 -732,000,000 -724,000,000 -758,000,000 -923,000,000 -868,000,000 
      benefit from inventory and doubtful accounts
    		          45,000,000 25,000,000 24,000,000 167,000,000 46,000,000 27,000,000 51,000,000 46,000,000 52,000,000 100,000,000 80,000,000 87,000,000 41,000,000 59,000,000 63,000,000 76,000,000 42,000,000 61,000,000 56,000,000 40,000,000 41,000,000      
      increase in cash, cash equivalents and restricted cash
    		       1,449,000,000    314,000,000 901,000,000   -1,320,000,000 896,000,000   -4,316,000,000 2,947,000,000                
      settlement of cash flow hedge
    		                               0    0 
      payments related to stock-based award activities
    		            14,000,000 -3,000,000 -57,000,000  9,000,000 7,000,000 -34,000,000                  
      cash dividends paid to non-controlling interests
    		               -10,000,000 0 0 -8,000,000  0       0         
      purchases of available-for-sale securities and other investments
    		               -16,000,000 -25,000,000 -12,000,000 -7,000,000 -23,000,000 -5,000,000 -14,000,000 -59,000,000 -6,000,000 -8,000,000 -20,000,000 -5,000,000 -1,000,000 -24,000,000 -5,000,000 -3,000,000 -14,000,000 -5,000,000 -19,000,000 -7,000,000 -116,000,000 
      maturities and sales of available-for-sale securities and other investments
    		               4,000,000 1,000,000 9,000,000 1,000,000 19,000,000 1,000,000 20,000,000 8,000,000 14,000,000 10,000,000 1,000,000 1,000,000 2,000,000 11,000,000   24,000,000 12,000,000 1,000,000 1,000,000 86,000,000 
      net (payments) proceeds related to stock-based award activities
    		                                    
      adjustments to reconcile net income to net cash from operating activities:
    		                                    
      contributions from non-controlling interests
    		                    0 0 1,000,000              
      cash dividends paid
    		                  -155,000,000 -154,000,000 -154,000,000 -154,000,000 -156,000,000 -147,000,000 -150,000,000 -154,000,000 -157,000,000 -164,000,000   -120,000,000 -105,000,000 -107,000,000 -107,000,000 -109,000,000 -92,000,000 
      dividends received from equity investee
    		                                    
      proceeds from business divestitures
    		                                   554,000,000 
      net proceeds (payments) related to stock-based award activities
    		                             72,000,000 17,000,000      
      net transfer of cash and cash equivalents to everett
    		                           0 0 -13,000,000 -28,000,000 -152,000,000 0    
      net transfer of cash and cash equivalents from seattle
    		                                    
      (payments) proceeds related to stock-based award activities
    		                    13,000,000                
      proceeds related to stock-based award activities
    		                      -43,000,000              
      (earnings) income from equity interests
    		                           -15,000,000 -11,000,000 10,000,000 -22,000,000      
      net proceeds related to stock-based award activities
    		                       24,000,000 15,000,000 26,000,000 -17,000,000 12,000,000         
      net transfer of cash and cash equivalents from (to) seattle
    		                                    
      cash dividend from everett
    		                               0 0    
      cash dividend from seattle
    		                                    
      restricted cash transfer
    		                                    
      (decrease) in cash, cash equivalents and restricted cash
    		                                    
      supplemental schedule of non-cash investing and financing activities:
    		                                    
      net assets transferred to everett and seattle
    		                                    
      financial collateral returned
    		                        233,000,000 226,000,000 281,000,000 134,000,000 402,000,000 787,000,000 144,000,000 417,000,000 0    
      net transfer of cash and cash equivalents to seattle
    		                              -70,000,000      
      gain on h3c and mphasis divestitures
    		                                    
      net transfers from former parent
    		                                    
      increase in cash and cash equivalents
    		                               1,822,000,000    1,967,000,000 
      cash and cash equivalents at beginning of period
    		                           0    0 0 0 12,987,000,000 0 
      cash and cash equivalents at end of period
    		                           -313,000,000    1,822,000,000 -344,000,000 -1,757,000,000 9,858,000,000 2,244,000,000 
      proceeds from (payments to) business divestitures
    		                            0        
      restricted cash - seattle debt issuance
    		                                    
      decrease in cash and cash equivalents
    		                                 -1,757,000,000 -3,129,000,000  
      benefit from doubtful accounts
    		                               20,000,000 15,000,000 7,000,000 -8,000,000 23,000,000 
      benefit from inventory
    		                               27,000,000 28,000,000 25,000,000 15,000,000 43,000,000 
      excess tax benefit from stock-based compensation
    		                               -27,000,000 -18,000,000 -24,000,000 -74,000,000 -11,000,000 
      income from equity interests
    		                               -1,000,000 -1,000,000 3,000,000 22,000,000 4,000,000 
      issuance of common stock under employee stock plans
    		                               45,000,000 101,000,000 107,000,000 158,000,000 40,000,000 
      issuance of senior notes relating to separation
    		                                    
      distribution of net proceeds of senior notes relating to separation, to former parent
    		                                    
      net transfers of property, plant and equipment from former parent
    		                                    
      gain on h3c divestiture
    		                                    
      (payments) proceeds from business divestitures
    		                                0 0 -20,000,000  
      net transfer from former parent
    		                                    
      cash held for sale
    		                                    
      net assets transferred to everett
    		                                0    
      issuance of debt
    		                                  248,000,000 292,000,000 
      net transfers from (to) former parent
    		                                    
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.